Manufacturing, Biologic Drugs

Outsourced Vaccine Development

July 02, 2009

The authors discuss how strategic outsourcing to contract manufacturing organizations that have technical and regulatory expertise can add further value during vaccine development.

HHS Orders H1N1 Vaccines and Vaccine Antigen

May 28, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

The United States Department of Health and Human Services (HHS) this week placed an initial order with Sanofi Pasteur (Lyon, France) for a vaccine to fight influenza A (H1N1) infection.

Global Warming Heats Up Need for Malaria Vaccine

September 02, 2008

With economics and politics in the way, can we defeat the malaria epidemic before it defeats us?

Company and People Notes: Merck to Expand North Carolina Vaccine Facility, PDI's Michael J. Marquard Retires, More...

June 26, 2008

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Stiefel Laboratories will acquire Barrier Therapeutics, Danube Pharmaceuticals appoints Brian Levy COO, more...

Requiem for a Vaccine

May 02, 2008

Scientists are giving up on a preventive vaccine for AIDS, but there are lessons to be learned.

Merck Issues Voluntary Recall of Two Vaccines

December 20, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck & Co. initiated a voluntary recall of 11 lots of its Haemophilus influenzae type B vaccine, Pedvaxhib, and two lots of its combination Haemophilus influenzae type B/ hepatitis B vaccine, Comvax.

Sanofi-Aventis to Build Vaccine Facility in China

November 29, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

Sanofi-aventis entered into an agreement with Chinese authorities allowing Sanofi to construct a vaccine-manufacturing plant in Shenzhen municipality.

Microbix Develops Team to Help Boost Flu Vaccine Production

August 16, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

Microbix Biosystems has established a team of experts to help manufacturers boost their production of influenza vaccine.

July 27, 2007 Notes: Merck & Co. Acquires NovaCardia, Sanofi Pasteur Completes Vaccine-Manufacturing Facility, More

July 27, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck & Co. acquires NovaCardia, Sanofi Pasteur completes vaccine-manufacturing facility, more

Novartis to Increase US Influenza Vaccine Supplies

July 12, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novartis Vaccines plans to produce approximately 40 million doses of its ?Fluvirin? vaccine for distribution in the United States during the 2007?2008 flu season.